A large-scale study has found that glucagon-like peptide-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, used to treat obesity and diabetes, are also effective in reducing the worsening of depression and anxiety disorder symptoms
Hypothalamic amylin receptor activation reduces food intake through complementary but distinct circuits from GLP-1 receptor-mediated satiety signaling
It is never only burning one type of fuel
Santos RB, Abranches R, Fischer R, Sack M, Holland T
At Genesis II, we believe in Preventive Maintenance, giving your scalp the tools it needs to resist shedding and jump back into the growth phase faster
Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease